financetom
Business
financetom
/
Business
/
GEO Group Starts Debt Refinancing Process
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GEO Group Starts Debt Refinancing Process
Apr 1, 2024 10:33 AM

01:12 PM EDT, 04/01/2024 (MT Newswires) -- GEO Group ( GEO ) said Monday that it started a refinancing process for its tranche 1 and 2 term loans, under which $906.7 million was outstanding as of the end of 2023.

The company said it is targeting $1.6 billion in secured and unsecured financing and a $310 million revolving credit facility to repay the term loans, its revolving credit facility, its outstanding 9.5% and 10.5% senior second lien secured notes due 2028, and 6% senior unsecured notes due 2026. Proceeds from the refinancing will also be used for general working capital, the company added.

GEO Group ( GEO ) said there is no assurance that any of the refinancing transactions will be completed. The company also said it will release the terms of proposed refinancing transactions upon completion.

Price: 14.35, Change: +0.23, Percent Change: +1.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Nov 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
BRIEF-Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.
BRIEF-Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.
Nov 21, 2025
Nov 21 (Reuters) - LAVA Therapeutics NV ( LVTX ): * XOMA ROYALTY ANNOUNCES CLOSING OF TRANSACTIONS TO ACQUIRE LAVA THERAPEUTICS N.V. Source text: Further company coverage: ...
Form 8.3
Form 8.3
Nov 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3
Form 8.3
Nov 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved